Advanced Modalities
Analytical & Bioanalytical Services
Chemistry, Manufacturing and Controls
Company Overview
About
VintaBio is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:United States
Founded:2001
Employees:1,991
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
Phase III Clinical Trials
Commercial Scale
Clinical
Markets Served
Europe
Regulatory Approvals
Drug Approval HXYUK9
FDA · #APR-WCTOZA2M · 2020-09-01
Drug Approval SRKUUF
EMA · #APR-2WE2B4AR · 2019-05-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-KCRFOWDM
Issued: 2020-06-27
Expires: 2025-03-22
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-W1RDJPDM
Issued: 2020-02-25
Expires: 2025-10-24
WHO GMP
World Health Organization
Cert #: CERT-Q7ASJL31
Issued: 2020-12-18
Expires: 2025-10-15
Loading CDMO intelligence...
Key facts about VintaBio
- VintaBio is headquartered in the United States.
- VintaBio was founded in 2001.
- VintaBio has 1,991 employees.
- VintaBio's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like VintaBio
Directory pages this company appears in, each with the full list of matching manufacturers.